[1]
|
Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products
Frontiers in Endocrinology,
2023
DOI:10.3389/fendo.2023.1126661
|
|
|
[2]
|
Persistence of improved glucose homeostasis in Gclm null mice with age and cadmium treatment
Redox Biology,
2022
DOI:10.1016/j.redox.2021.102213
|
|
|
[3]
|
Role of ferroptosis inhibitors in the management of diabetes
BioFactors,
2022
DOI:10.1002/biof.1920
|
|
|
[4]
|
Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?
Biologia Futura,
2021
DOI:10.1007/s42977-021-00092-2
|
|
|
[5]
|
Inhibiting miR‐27a and miR‐142‐5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway
IUBMB Life,
2020
DOI:10.1002/iub.2221
|
|
|
[6]
|
Inhibiting miR‐27a and miR‐142‐5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway
IUBMB Life,
2020
DOI:10.1002/iub.2221
|
|
|
[7]
|
An in vitro protocol to study the effect of hyperglycemia on intracellular redox signaling in human retinal pigment epithelial (ARPE-19) cells
Molecular Biology Reports,
2019
DOI:10.1007/s11033-019-04597-x
|
|
|
[8]
|
Lutein reverses hyperglycemia-mediated blockage of Nrf2 translocation by modulating the activation of intracellular protein kinases in retinal pigment epithelial (ARPE-19) cells
Journal of Cell Communication and Signaling,
2019
DOI:10.1007/s12079-019-00539-1
|
|
|
[9]
|
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Molecular Neurobiology,
2018
DOI:10.1007/s12035-018-0961-8
|
|
|
[10]
|
Amelioration of diabetes-induced testicular and sperm damage in rats by cerium oxide nanoparticle treatment
Andrologia,
2018
DOI:10.1111/and.13089
|
|
|
[11]
|
Effects of CeO2 nanoparticles on the HO-1, NQO1, and GCLC expression in the testes of diabetic rats
Canadian Journal of Physiology and Pharmacology,
2018
DOI:10.1139/cjpp-2017-0784
|
|
|
[12]
|
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
Nat. Prod. Rep.,
2014
DOI:10.1039/C3NP70065H
|
|
|